𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Renal function in renal or liver transplant recipients after conversion from a calcineurin inhibitor to sirolimus

✍ Scribed by L. Bäckman; A. Varberg Reisæter; L. Wramner; B.-G. Ericzon; K. Salmela; C. Brattström


Book ID
110889669
Publisher
John Wiley and Sons
Year
2006
Tongue
English
Weight
79 KB
Volume
20
Category
Article
ISSN
0902-0063

No coin nor oath required. For personal study only.


📜 SIMILAR VOLUMES


Improvement of renal function after the
✍ Javier F. Castroagudín; Esther Molina; Rafael Romero; Esteban Otero; Santiago To 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 141 KB 👁 1 views

Chronic renal dysfunction is a frequent and severe complication in solid-organ transplant recipients. Calcineurin inhibitors (CNIs) are the main pathogenic factors of renal dysfunction. Switching from CNIs to nonnephrotoxic drugs, such as mammalian target of rapamycin inhibitors (everolimus and siro

A randomized controlled trial of late co
✍ Christopher J.E. Watson; Alexander E.S. Gimson; Graeme J. Alexander; Michael E.D 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 307 KB 👁 1 views

Renal impairment is common in patients after liver transplantation and is attributable in large part to the use of calcineurin inhibitor (CNI)-based immunosuppression. We sought to determine whether conversion to sirolimus-based immunosuppression was associated with improved renal function. In a sin